Purpose. Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a major challenge for global healthcare systems. The objectives of this study were to determine the nosocomial spread of CRKP clones and analyse the molecular characteristics of CRKP in our hospital.
INTRODUCTION
Carbapenem-resistant Enterobacteriaceae (CRE) present a serious problem for infection control and are recognized as a global health concern. In the Asia-Pacific region, IMPtype carbapenemase, New Delhi metallo-b-lactamase (NDM) and Klebsiella pneumoniae carbapenemase (KPC) are clinically and epidemiologically the most important enzymes in CRE. In Taiwan, the predominantly plasmidmediated carbapenemases are class A KPC-2 and class B metallo-b-lactamase IMP-8 [1] . Prior studies, conducted in Taiwan, revealed that extended-spectrum b-lactamase (ESBL) production, AmpC b-lactamase overproduction, loss of outer membrane protein, up-regulation of efflux pumps and class D OXA-48 production have sporadically been described in these CRE strains [2, 3] .
Over the past decade, OXA-48-producing members of the family Enterobacteriaceae have spread extensively throughout Mediterranean countries and other global regions, but have remained uncommon in Asia [4, 5] . Expanded-spectrum oxacillinase OXA-48 is still rarely reported in Taiwan [6] . In 2012, the emergence of four OXA-48-producing K. pneumoniae isolates revealed that the bla OXA-48 gene was recently detected in IncA/C plasmids, first reported from a 4-year surveillance program in Taiwan [3] . In addition, three of the four OXA-48-producing K. pneumoniae isolates belong to multi-locus sequence typing (MLST) ST11 and harbour bla CTX-M genes. ST11 is also the predominant KPC clone that has circulated in Taiwan in recent years [7, 8] . These ST11 OXA-48-producing K. pneumoniae isolates also carry a combination of bla ESBL and bla AmpC [9] .
Our hospital is a teaching hospital, located in central Taiwan, with a total capacity of 1349 beds including 100 in five intensive care units (ICUs). Since the first half of 2014, we have noticed a marked increase in the number of clinical isolates of carbapenem-resistant K. pneumoniae (CRKP) in our hospital (3 isolates in the second half of 2013, 26 in the first half of 2014 and 90 in the second half of 2014). An active surveillance programme for carbapenemase-producing Enterobacteriaceae, using rectal swabs from patients admitted to our five ICUs, has been ongoing since November 2014. We conducted this study to investigate the clinical and microbiological characteristics of CPKP in our hospital.
METHODS
Demographics of patients infected or colonized with carbapenem-resistant Klebsiella pneumoniae Ninety-eight consecutive and non-duplicated (the first isolate obtained from each patient) ertapenem-or imipenemresistant K. pneumoniae isolates, including clinical and surveillance isolates, were collected from March 2014-June 2015. These isolates were identified with the API 20E system. The demographic data reviewed included patients' sex and age, ward and source of specimen. Isolates were stored at À70 C in 20 % (v/v) glycerol containing Luria-Bertani broth. E. coli J53 Azide R was used as the recipient strain for conjugation. E. coli ATCC 25922 was used as the reference strain for testing of antimicrobial susceptibility.
Antimicrobial susceptibility testing and phenotypic screening The minimal inhibitory concentrations (MICs) of imipenem, ertapenem, cefepime, ceftazidime, cefotaxime, ceftriaxone, cefmetazole, piperacillin-tazobactam, ciprofloxacin, levofloxacin, gentamicin, amikacin, trimethoprim-sulfamethoxazole, tigecycline and colistin were obtained using the BD Phoenix Automated Microbiology System (Franklin Lakes, NJ). Susceptibility breakpoints were interpreted as per the recommendations of the Clinical and Laboratory Standards Institute [10] . Susceptibility to tigecycline was determined according to FDA-approved criteria (susceptible 2 µg ml
À1
; intermediate=4 µg ml
; resistant !8 µg ml À1 ). Escherichia coli ATCC 25922 was used for quality control. [13] , ESBL genes (e.g. bla CTX-M , bla TEM , and bla SHV ) [14] [15] [16] [17] and genes encoding for common aminoglycoside-modifying enzymes (AMEs) (armA, rmtB, aac(6¢)-Ib, aac(3)-IVa, ant(2¢¢)-Ia and aph(3¢)-Ia) [18, 19] were detected by PCR amplification. The amplicons were sequenced, and the entire sequence of each gene was compared to sequences in the GenBank nucleotide database using the BLAST algorithm (http://www.ncbi.nlm.nih.gov/ blast/).
PCR detection and DNA sequencing

Conjugation experiment and plasmid analysis
The conjugation transfer assay was performed in broth culture using E. coli J53 Azr as the recipient. The recipient cells were grown at 37 C in fresh LB broth (30 ml in 250 ml flasks) containing sodium azide (100 µg ml
À1
) for 24 h. The donor cells were grown overnight at 37 C in LB medium with shaking. Strains were separately inoculated with an initial OD 600 of 0.2 and grown until OD 600 was 1.0. Donor and recipient cells were mixed at a ratio of 1 : 10 and centrifuged at 5000 g for 5 min. The pellet was resuspended in sufficient LB broth to suspend the cells. The cell suspension was dropped onto a piece of nylon membrane (4 cm 2 ) on an LB agar plate. The conjugation mixture was washed once with 10 mM MgSO 4 after incubating at 37 C for 16 h. Transconjugants were selected on MacConkey agar containing cefotaxime (2 µg ml
) and supplemented with sodium azide (120 µg ml
). The colonies grown on the selection media were selected and the species were identified using the Phoenix bacterial identification system (NMIC/ID-411 cards; Becton, Dickinson Diagnostic Instrument Systems, Sparks, MD) as previously described [20] . The plasmid DNA was extracted by the alkaline lysis method and purified using a commercial plasmid DNA purification kit (Genemark, Taichung, Taiwan). Plasmid replicons were typed by PCR-based replicon typing method as previously described [21] . Five multiplex and three simplex PCR assays involving 18 pairs of primers were used to recognize the 18 incompatibility groups, including HI1, HI2, I1-Ig, X, L/M, N, FIA, FIB, W, Y, P, FIC, A/C, T, FIIAs, F, K and B/O.
Pulsed-field gel electrophoresis
The preparation of PFGE plugs and digestion with XbaI (New England Biolabs) was performed as per the manufacturer's guidelines. The DNA fragments were separated by electrophoresis using a CHEF-DR III apparatus (Bio-Rad Laboratories, Hercules, CA). DNA fragments were resolved on 1.0 % SeaKem LE agarose gel at 12 C; electrophoresis was performed for 21 h at 6 V cm À1 with a 2.2-54.2-s linear switch ramp. XbaI-digested DNAs samples from Salmonella enterica subsp. enterica serotype Braenderup H9812 were used as molecular size markers. The PFGE patterns were analysed by GelCompar II 6.5 software (Applied Maths, Belgium). PFGE patterns were assigned to clusters according to the criteria proposed by Tenover et al. [22] . Two strains were considered identical when they exhibited an exact match of band patterns, and were believed to be of the same cluster if they exhibited up to six band differences and had a genetic similarity >70 % in both lanes.
Multi-locus sequence typing
Amplification and sequencing of the seven housekeeping genes for MLST were performed on the 98 K. pneumoniae isolates according to the protocol described on the K. pneumoniae MLST website (http://bigsdb.pasteur.fr/klebsiella/). MLST results were typed according to the international K. pneumoniae MLST database created in 2005 at the Pasteur Institute, Paris.
Statistical analysis
Statistical analyses were performed using SPSS software package (version 17, Chicago, IL, USA). Analysis was performed by either the chi-square test or Fisher's exact test for categorical variables. A value of P<0.05 was considered statistically significant.
RESULTS
Demographics and clinical parameters A total of 98 patients (66 male, 67 %) in the age range 11-94 years (mean±SD, 67.71±15.11) were enrolled. Twenty-six patients had cultures positive for CRKP within 48 h of admission. Among these 26 patients, 7 were referred from other hospitals or nursing centres and the remaining 19 were from their respective households. The 72 patients whose cultures tested positive for CRKP 48 h after admission were from the following wards: chronic respiratory care ward, 7; general ward, 16; cardiac ICU, 3; first medical ICU, 11; second medical ICU, 25; first surgical ICU, 6; and second surgical ICU, 4. The monthly number of patients with CRKP is summarized in Fig. 1 . Of the 98 CRKP isolates, 73 (74 %) were obtained from surveillance rectal swab cultures and 25 (26 %) from clinical specimens, including 13 (13 %) from urine, 4 (4 %) from blood, 4 (4 %) from sputum, 3 (3 %) from pus and 1 (1 %) from the tip of a central venous catheter. CRKP colonization and infection were diagnosed in 20 and 5 patients, respectively. Among the 5 CRKP infection patients, 4 had bacteraemia and 1 had pneumonia; two patients had received imipenem within 3 months of positive CRKP culture and only one patient died from CRKP infection. Antimicrobial susceptibility and prevalence of antimicrobial resistance genes Distribution of antimicrobial susceptibility, MICs for the tested antimicrobial agents and the susceptibilities of all 98 CRKP isolates are shown in Table 1 . Tigecycline showed excellent in vitro activity (85 % susceptible) against these CRKP isolates. Ninety-seven per cent of the CRKP isolates were susceptible to colistin, as assessed by the BD Phoenix Fig. 2 . Pulsed-field gel electrophoresis patterns, sequence types, presence of carbapenemase, CTX-M,DHA-1, SHV-11 and rmtB, and minimum inhibitory concentrations of cefotaxime and imipenem assessed for 98 carbapenem-resistant isolates of Klebsiella pneumoniae.
Typing analysis by PFGE and MLST
Automated Microbiology System (Franklin Lakes, NJ). This result should be interpreted with caution, because an automated device may underestimate resistance to colistin [23, 24] .
The presence of genes encoding carbapenemases was confirmed by PCR and DNA sequencing. Ninety-six isolates (98 %) were positive for carbapenemase, including K. pneumoniae carbapenemase KPC-2 (n=82), OXA-48 (n=64), VIM-1 (n=2) and IMP-8 (n=1). There were 50 isolates with more than one carbapenemase-encoding gene: 47 isolates contained bla KPC-2 and bla OXA-48 ; 2 isolates contained bla KPC-2 , bla OXA-48; and bla VIM-1 , and 1 isolate contained bla KPC-2 , bla OXA-48 and bla IMP-8 . The prevalence of co-production of carbapenemases, ESBL and AmpC b-lactamase is detailed in Table 2 .
Selected carbapenemase-encoding plasmids were successfully transferred to a laboratory strain of E. coli J53-2 (Table 3) . Replicon typing identified numerous plasmid incompatibility (Inc) groups among the transconjugants of these carbapenemase-positive and/or those in combination with CTX-M or DHA-1 isolates. The results demonstrated that these b-lactamase producers encoded more drug resistance genes by carrying more (1-3) plasmids. The carbapenemase-producing transconjugants expressed resistance to cefotaxime and imipenem with carbapenemase phenotypes, similar to that observed in their parental strains. Of note, IncA/C was almost exclusively detected in the OXA-48-producing transconjugants. The antimicrobial resistance gene bla KPC-2 was found to be carried on the IncF group (F or FIIK) replicon. Phenotypic and genotypic confirmation of six selected carbapenemase-positive strains and their transconjugants are shown in Table 3 .
No isolates harboured the bla GIM , bla SIM , bla SPM and bla NDM-1-type genes. Most of the b-lactamase genes were transferable in conjugation experiments, suggesting that both horizontal transfer and clonal spread contributed to the increased prevalence of carbapenemase in K. pneumoniae. The other class A b-lactamases in each isolate were similarly identified as bla SHV-11 (n=94). The genes bla SHV and rmtB were present in 94 (96 %) and 54 (55 %) isolates, respectively; 65 (66 %) and 51 (52 %) isolates were resistant to gentamicin and amikacin, respectively. Most gentamicinresistant (78 %, 51/65) and amikacin-resistant (90 %, 46/51) isolates carried rmtB. The genes armA, aph(3¢)-Ia and aac (6¢)-Ib were present in 2 (2 %), 6 (6 %) and 11 (11 %) isolates, respectively. All study isolates were negative for genes aac(3)-IVa and ant(2'')-Ia.
DISCUSSION
This study describes the epidemiology of and the phenotypic and molecular characteristics involved in the acquisition and dissemination of OXA-48-KP and KPC-2-KP at a hospital in central Taiwan. Our results indicated extensive clonal dissemination. We also found that 98 % (49/50) of the isolates with KPC-2 and OXA-48 belonged to the same PFGE cluster (L) and the same sequence type (ST11); 42 % (21/50) of the isolates were obtained from the second medical ICU patients (17 of 21 isolates were obtained from April-June 2015). To the best of our knowledge, our study is the first to report such a large group of OXA-48 b-lactamases with clonal dissemination among carbapenemresistant K. pneumoniae in Taiwan.
Recent data suggest that CRE-producing OXA-48 are more prevalent in Europe, the Mediterranean, and North Africa [25] . The prevalence of carbapenem-resistant K. pneumoniae (CRKP) strains that can produce the OXA-48-enzyme with different sequence types is gradually increasing in Asian hospitals [3, 6, 26, 27] , because of clonal dissemination and horizontal gene transfer. A disseminated ST11 KPC-KP clone has been identified in China, Japan and Korea [28] . KPC-2 was previously regarded as the most prevalent type of carbapenemase among K. pneumoniae strains in Taiwanese medical centres [29, 30] . The selected carbapenemase-producing transconjugants carried the gene and expressed carbapenemase, similar to their parental strains, suggesting that carbapenem-resistance genes are located on self-transferable plasmids. In addition, OXA-48 is located on the IncA/C plasmid and KPC-2 is located on the IncF group, similar to that previously reported in Taiwan [3, 31] .
The co-existence of genes coding for at least two classes of carbapenemase in K. pneumoniae has been reported worldwide, co-harbouring two carbapenemases including [32] . One K. pneumoniae isolate with both IMP-4 and NDM-1 and one K. oxytoca isolate with both KPC-2 and IMP-8 were also recently detected in China [33] . Co-production of OXA-48 and other carbapenemases is infrequently reported [34] [35] [36] , with few reports worldwide and none in Taiwan. The co-existence of bla OXA-48 and truncated bla NDM-1 in one K. pneumoniae clinical isolate was first reported in China [36] . Co-production of KPC-2 and OXA-48 in a single strain has not previously been detected. The detection of KPC-2 and OXA-48 co-production in a single K. pneumoniae strain in our study is significant, highlighting the continuous emergence and increasing diversity of carbapenemases within K. pneumoniae in Taiwan. Although Ma et al. [3] isolated four OXA-48-producing K. pneumoniae strains in Taiwan, they did not demonstrate the co-existence of other carbapenemases. To the best of our knowledge, coexistence of the A-, B-and D-classes of carbapenemases, namely, KPC-2, OXA-48 and VIM-1 (n=2), as well as KPC-2, OXA-48 and IMP-8 (n=1), in a single CRKP strain was first detected in our study. Our present study showed the clonal dissemination of K. pneumoniae isolates producing multiple carbapenemases (predominantly KPC-2 and OXA-48, with three isolates also producing third carbapenemase) in one strain in Taiwan.
Typing analysis of multi-locus sequence types revealed that the ST11 K. pneumoniae strain was the predominant KPC clone throughout Taiwan in 2012 [29, 31] . Our findings are representative of a K. pneumoniae outbreak in our medical ICUs, involving KPC-2-and OXA-48-producing K. pneumoniae ST11. The isolates of PFGE cluster L shared the same MLST sequence type (ST11). This may explain the intra-hospital spread of KPC-2-and OXA-48-positive K. pneumoniae presently occurring in Taiwan. Cocarriage of the genes ESBL and AmpC, alone or in combination, is also noted among ST11 KPC-2 isolates in Taiwan and China [31, 37] . We also found that most isolates in ST11 and PFGE cluster L harboured multiple resistance genes, including bla KPC-2 , bla OXA-48 , bla CTX-M-14 , rmtB and bla SHV-11 , confirming the complexity of KPC-KP epidemiology and the need for ongoing monitoring to prevent spread.
In conclusion, K. pneumoniae with carbapenemases, ESBLs and AmpC b-lactamases may be an emerging high-risk multidrug-resistant clone. A single strain of ST11 CRKP harbouring three classes of carbapenemase genes (bla OXA-48 , bla KPC-2 , bla VIM-2 or bla IMP-8 ) has not previously been identified in other hospitals. The strains of two carbapenemaseproducing K. pneumoniae, described in our study, may already be far more prevalent than was realized previously. This may particularly apply to the presence of OXA-48 b-lactamase among K. pneumoniae in Taiwan. These findings are not surprising, considering the reports of clonal spread of K. pneumoniae harbouring OXA-48 in south Asia. The potential global spread of this organism has been anticipated.
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